The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Deshpande Milind since 2011.
The trader's CIK number is 1378588.
At the time of the last reporting, Deshpande Milind was the Pres R&D and CSO of Achillion Pharmaceuticals Inc. (stock ticker symbol ACHN).
Also see all insider trading activities at Achillion Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | ACHN | 0 | $0 | 100,000 | $1,500,000 | 100,000 | $302,000 |
| 2014 | ACHN | 0 | $0 | 216,624 | $2,166,240 | 216,624 | $619,111 |
| 2012 | ACHN | 0 | $0 | 15,937 | $156,075 | 15,937 | $16,733 |
| 2011 | ACHN | 0 | $0 | 113,113 | $863,801 | 97,488 | $122,833 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-01-21 | ACHN | Option Ex | 100,000 | 3.02 | 302,000 |
| 2015-01-21 | ACHN | Sale | 100,000 | 15.00 | 1,500,000 |
| 2014-08-18 | ACHN | Option Ex | 216,624 | 2.86 | 619,111 |
| 2014-08-18 | ACHN | Sale | 216,624 | 10.00 | 2,166,240 |
| 2012-03-15 | ACHN | Sale | 5,312 | 10.70 | 56,838 |
| 2012-03-15 | ACHN | Option Ex | 5,312 | 1.05 | 5,577 |
| 2012-01-09 | ACHN | Sale | 10,625 | 9.34 | 99,237 |
| 2012-01-09 | ACHN | Option Ex | 10,625 | 1.05 | 11,156 |
| 2011-06-28 | ACHN | Option Ex | 49,688 | 1.46 | 72,643 |
| 2011-06-28 | ACHN | Sale | 49,688 | 8.28 | 411,267 |
| 2011-06-22 | ACHN | Sale | 10,800 | 7.51 | 81,064 |
| 2011-06-23 | ACHN | Sale | 4,825 | 7.50 | 36,201 |
| 2011-05-27 | ACHN | Option Ex | 47,800 | 1.05 | 50,190 |
| 2011-05-27 | ACHN | Sale | 47,800 | 7.01 | 335,269 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Deshpande Milind (Pres R&D and CSO of Achillion Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.